|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.035 USD | +0.31% |
|
+8.41% | -28.98% |
| 05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
Altimmune, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.005 million compared to USD 0.021 million a year ago. Net loss was USD 24.39 million compared to USD 20.07 million a year ago.
Basic loss per share from continuing operations was USD 0.34 compared to USD 0.4 a year ago. Diluted loss per share from continuing operations was USD 0.34 compared to USD 0.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.98% | 568M | |
| +9.81% | 115B | |
| +11.84% | 106B | |
| -3.00% | 21.96B | |
| -13.88% | 21.87B | |
| -5.29% | 19.21B | |
| -3.39% | 18.08B | |
| -38.57% | 17.71B | |
| +6.39% | 14.32B | |
| +33.83% | 12.42B |
ALTIMMUNE, INC. 
